KG

Kolley Girijyoshna

Active Director Director DIN 10109979
DIN 10109979 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Kolley Girijyoshna

Data last updated:

Kolley Girijyoshna is a Director at Aventos Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10109979
Primary Designation Director
Industry Pharma
First Appointment 15 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Mar 20232023Active

Board colleagues of Kolley Girijyoshna

NameDINCompanyDesignation
Muni Kalyani Vuribindi10109980Aventos Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aventos Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kolley Girijyoshna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kolley Girijyoshna

Kolley Girijyoshna currently holds 1 directorship: Aventos Pharmaceuticals Private Limited (Director, since 15 Mar 2023).

Kolley Girijyoshna was first appointed on 15 Mar 2023 as Director at Aventos Pharmaceuticals Private Limited.

The current boards of Kolley Girijyoshna's companies include Muni Kalyani Vuribindi (Aventos Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available